Failure of human fibroblast interferon to protect against rhinovirus infection
- PMID: 6158933
- DOI: 10.1007/BF01317324
Failure of human fibroblast interferon to protect against rhinovirus infection
Abstract
Volunteers were treated with fibroblast interferon or placebo nose drops for four days. On the second day, they received a challenge with rhinovirus type 4. There was no difference in the clinical symptoms or viral shedding between the two groups. The possible reasons for this result are discussed.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical